annual cash & cash equivalents:
$242.08M-$157.19M(-39.37%)Summary
- As of today (June 22, 2025), IONS annual cash & cash equivalents is $242.08 million, with the most recent change of -$157.19 million (-39.37%) on December 31, 2024.
- During the last 3 years, IONS annual cash & cash equivalents has fallen by -$627.11 million (-72.15%).
- IONS annual cash & cash equivalents is now -72.15% below its all-time high of $869.19 million, reached on December 31, 2021.
Performance
IONS Cash and cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly cash & cash equivalents:
$264.19M+$22.11M(+9.14%)Summary
- As of today (June 22, 2025), IONS quarterly cash & cash equivalents is $264.19 million, with the most recent change of +$22.11 million (+9.14%) on March 31, 2025.
- Over the past year, IONS quarterly cash & cash equivalents has dropped by -$84.70 million (-24.28%).
- IONS quarterly cash & cash equivalents is now -69.60% below its all-time high of $869.19 million, reached on December 31, 2021.
Performance
IONS quarterly cash & cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash and cash equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
IONS Cash and cash equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -39.4% | -24.3% |
| 3 y3 years | -72.2% | -51.3% |
| 5 y5 years | -64.6% | -45.7% |
IONS Cash and cash equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -72.2% | at low | -51.3% | +9.1% |
| 5 y | 5-year | -72.2% | at low | -69.6% | +9.1% |
| alltime | all time | -72.2% | >+9999.0% | -69.6% | >+9999.0% |
IONS Cash and cash equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $264.19M(+9.1%) |
| Dec 2024 | $242.08M(-39.4%) | $242.08M(-27.7%) |
| Sep 2024 | - | $334.61M(+13.8%) |
| Jun 2024 | - | $293.99M(-15.7%) |
| Mar 2024 | - | $348.89M(-12.6%) |
| Dec 2023 | $399.27M(+44.4%) | $399.27M(+13.4%) |
| Sep 2023 | - | $352.06M(-17.1%) |
| Jun 2023 | - | $424.79M(+37.5%) |
| Mar 2023 | - | $309.03M(+11.8%) |
| Dec 2022 | $276.47M(-68.2%) | $276.47M(-12.2%) |
| Sep 2022 | - | $314.99M(-39.6%) |
| Jun 2022 | - | $521.92M(-3.8%) |
| Mar 2022 | - | $542.51M(-37.6%) |
| Dec 2021 | $869.19M(+118.6%) | $869.19M(+37.3%) |
| Sep 2021 | - | $632.95M(+12.0%) |
| Jun 2021 | - | $565.12M(+36.5%) |
| Mar 2021 | - | $414.15M(+4.1%) |
| Dec 2020 | $397.66M(-41.8%) | $397.66M(-37.2%) |
| Sep 2020 | - | $633.06M(+19.4%) |
| Jun 2020 | - | $530.18M(+9.0%) |
| Mar 2020 | - | $486.19M(-28.8%) |
| Dec 2019 | $683.29M(+145.1%) | $683.29M(+175.6%) |
| Sep 2019 | - | $247.94M(-9.0%) |
| Jun 2019 | - | $272.52M(-27.5%) |
| Mar 2019 | - | $375.81M(+34.8%) |
| Dec 2018 | $278.82M(+115.1%) | $278.82M(-41.9%) |
| Sep 2018 | - | $479.89M(-40.4%) |
| Jun 2018 | - | $805.49M(+254.1%) |
| Mar 2018 | - | $227.50M(+75.5%) |
| Dec 2017 | $129.63M(+53.1%) | $129.63M(-18.6%) |
| Sep 2017 | - | $159.18M(+19.7%) |
| Jun 2017 | - | $132.99M(+16.4%) |
| Mar 2017 | - | $114.22M(+34.9%) |
| Dec 2016 | $84.69M(-34.2%) | $84.69M(+0.5%) |
| Sep 2016 | - | $84.28M(-25.1%) |
| Jun 2016 | - | $112.53M(+20.6%) |
| Mar 2016 | - | $93.34M(-27.5%) |
| Dec 2015 | $128.80M(-9.9%) | $128.80M(+1.7%) |
| Sep 2015 | - | $126.59M(+5.9%) |
| Jun 2015 | - | $119.49M(-19.5%) |
| Mar 2015 | - | $148.35M(+3.7%) |
| Dec 2014 | $143.00M(-10.6%) | $143.00M(+95.3%) |
| Sep 2014 | - | $73.22M(-22.2%) |
| Jun 2014 | - | $94.08M(-41.8%) |
| Mar 2014 | - | $161.78M(+1.1%) |
| Dec 2013 | $159.97M(+28.5%) | $159.97M(-37.6%) |
| Sep 2013 | - | $256.41M(-13.5%) |
| Jun 2013 | - | $296.54M(+175.5%) |
| Mar 2013 | - | $107.65M(-13.5%) |
| Dec 2012 | $124.48M(+90.1%) | $124.48M(+47.2%) |
| Sep 2012 | - | $84.56M(-1.3%) |
| Jun 2012 | - | $85.64M(+51.9%) |
| Mar 2012 | - | $56.39M(-13.9%) |
| Dec 2011 | $65.48M(-6.5%) | $65.48M(+18.5%) |
| Sep 2011 | - | $55.26M(-35.0%) |
| Jun 2011 | - | $85.02M(-1.4%) |
| Mar 2011 | - | $86.20M(+23.1%) |
| Dec 2010 | $70.05M(-33.4%) | $70.05M(-30.0%) |
| Sep 2010 | - | $100.12M(+117.5%) |
| Jun 2010 | - | $46.04M(-53.3%) |
| Mar 2010 | - | $98.59M(-6.3%) |
| Dec 2009 | $105.25M(-51.7%) | $105.25M(-29.5%) |
| Sep 2009 | - | $149.29M(-30.8%) |
| Jun 2009 | - | $215.79M(-15.1%) |
| Mar 2009 | - | $254.06M(+16.6%) |
| Dec 2008 | $217.92M(+57.2%) | $217.92M(-17.7%) |
| Sep 2008 | - | $264.68M(-40.6%) |
| Jun 2008 | - | $445.72M(+63.9%) |
| Mar 2008 | - | $271.94M(+96.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2007 | $138.61M(+21.0%) | $138.61M(+35.4%) |
| Sep 2007 | - | $102.40M(-23.0%) |
| Jun 2007 | - | $132.96M(-27.5%) |
| Mar 2007 | - | $183.42M(+60.2%) |
| Dec 2006 | $114.51M(+3037.4%) | $114.51M(+9.9%) |
| Sep 2006 | - | $104.24M(-1.1%) |
| Jun 2006 | - | $105.36M(+6057.7%) |
| Mar 2006 | - | $1.71M(-53.1%) |
| Dec 2005 | $3.65M(-86.6%) | $3.65M(-93.1%) |
| Sep 2005 | - | $53.22M(+566.3%) |
| Jun 2005 | - | $7.99M(-33.5%) |
| Mar 2005 | - | $12.01M(-55.9%) |
| Dec 2004 | $27.25M(-17.7%) | $27.25M(+27.1%) |
| Sep 2004 | - | $21.45M(-29.4%) |
| Jun 2004 | - | $30.37M(-23.6%) |
| Mar 2004 | - | $39.76M(+20.1%) |
| Dec 2003 | $33.12M(-67.5%) | $33.12M(-40.6%) |
| Sep 2003 | - | $55.79M(-34.6%) |
| Jun 2003 | - | $85.32M(+39.7%) |
| Mar 2003 | - | $61.09M(-40.0%) |
| Dec 2002 | $101.86M(-19.8%) | $101.86M(+9.4%) |
| Sep 2002 | - | $93.08M(-15.4%) |
| Jun 2002 | - | $110.02M(+19.0%) |
| Mar 2002 | - | $92.45M(-27.2%) |
| Dec 2001 | $127.01M(+220.6%) | $127.01M(+931.7%) |
| Sep 2001 | - | $12.31M(-3.3%) |
| Jun 2001 | - | $12.74M(+58.1%) |
| Mar 2001 | - | $8.06M(-79.7%) |
| Dec 2000 | $39.62M(+12.2%) | $39.62M(-32.9%) |
| Sep 2000 | - | $59.03M(-4.9%) |
| Jun 2000 | - | $62.04M(-4.2%) |
| Mar 2000 | - | $64.73M(+83.4%) |
| Dec 1999 | $35.30M(+27.9%) | $35.30M(-7.8%) |
| Sep 1999 | - | $38.30M(+11.3%) |
| Jun 1999 | - | $34.40M(+69.5%) |
| Mar 1999 | - | $20.30M(-26.4%) |
| Dec 1998 | $27.60M(-27.6%) | $27.60M(-27.4%) |
| Sep 1998 | - | $38.00M(-2.3%) |
| Jun 1998 | - | $38.90M(+39.9%) |
| Mar 1998 | - | $27.80M(-27.0%) |
| Dec 1997 | $38.10M(+2.7%) | $38.10M(+31.8%) |
| Sep 1997 | - | $28.90M(-19.5%) |
| Jun 1997 | - | $35.90M(+37.0%) |
| Mar 1997 | - | $26.20M(-29.4%) |
| Dec 1996 | $37.10M(-20.2%) | $37.10M(+43.8%) |
| Sep 1996 | - | $25.80M(+1.2%) |
| Jun 1996 | - | $25.50M(+12.8%) |
| Mar 1996 | - | $22.60M(-51.4%) |
| Dec 1995 | $46.50M(+260.5%) | $46.50M(+87.5%) |
| Sep 1995 | - | $24.80M(+31.9%) |
| Jun 1995 | - | $18.80M(+13.3%) |
| Mar 1995 | - | $16.60M(+28.7%) |
| Dec 1994 | $12.90M(-61.7%) | $12.90M(-20.4%) |
| Sep 1994 | - | $16.20M(-12.0%) |
| Jun 1994 | - | $18.40M(-44.6%) |
| Mar 1994 | - | $33.20M(-1.5%) |
| Dec 1993 | $33.70M(+104.2%) | $33.70M(+88.3%) |
| Sep 1993 | - | $17.90M(-17.5%) |
| Jun 1993 | - | $21.70M(-19.6%) |
| Mar 1993 | - | $27.00M(+63.6%) |
| Dec 1992 | $16.50M(-22.2%) | $16.50M(+13.0%) |
| Sep 1992 | - | $14.60M(+10.6%) |
| Jun 1992 | - | $13.20M(-17.5%) |
| Mar 1992 | - | $16.00M(-24.5%) |
| Dec 1991 | $21.20M(+1077.8%) | $21.20M(+17.1%) |
| Sep 1991 | - | $18.10M(-46.1%) |
| Jun 1991 | - | $33.60M(+115.4%) |
| Mar 1991 | - | $15.60M(+766.7%) |
| Dec 1990 | $1.80M | $1.80M |
FAQ
- What is Ionis Pharmaceuticals annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Ionis Pharmaceuticals?
- What is Ionis Pharmaceuticals annual cash & cash equivalents year-on-year change?
- What is Ionis Pharmaceuticals quarterly cash & cash equivalents?
- What is the all time high quarterly cash & cash equivalents for Ionis Pharmaceuticals?
- What is Ionis Pharmaceuticals quarterly cash & cash equivalents year-on-year change?
What is Ionis Pharmaceuticals annual cash & cash equivalents?
The current annual cash & cash equivalents of IONS is $242.08M
What is the all time high annual cash & cash equivalents for Ionis Pharmaceuticals?
Ionis Pharmaceuticals all-time high annual cash & cash equivalents is $869.19M
What is Ionis Pharmaceuticals annual cash & cash equivalents year-on-year change?
Over the past year, IONS annual cash & cash equivalents has changed by -$157.19M (-39.37%)
What is Ionis Pharmaceuticals quarterly cash & cash equivalents?
The current quarterly cash & cash equivalents of IONS is $264.19M
What is the all time high quarterly cash & cash equivalents for Ionis Pharmaceuticals?
Ionis Pharmaceuticals all-time high quarterly cash & cash equivalents is $869.19M
What is Ionis Pharmaceuticals quarterly cash & cash equivalents year-on-year change?
Over the past year, IONS quarterly cash & cash equivalents has changed by -$84.70M (-24.28%)